Article Details
Retrieved on: 2022-08-30 11:18:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs (“MAIA”), today ...
Article found on: www.bakersfield.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here